Mastering skills in the training Network for attention deficit hyperactivity and...
Mastering skills in the training Network for attention deficit hyperactivity and autism spectrum Disorders
Attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are frequent, chronic and highly heritable neurodevelopmental disorders. Despite their societal importance, progress in understanding disease biol...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
GENCODYS
Genetic and Epigenetic Networks in Cognitive Dysfunction
16M€
Cerrado
CANDY
Comorbid Analysis of Neurodevelopmental Disorders and Epilep...
6M€
Cerrado
GRASAD
Uncovering the genetic roots of ASD and ADHD
161K€
Cerrado
SAF2012-33484
ANALISIS CRUZADO DE TRASTORNOS PSIQUIATRICOS: CONTRIBUCION D...
140K€
Cerrado
GEVAD
Rare and Common Genetic Variants analysis in ASDs and ADHD
153K€
Cerrado
SAF2015-68341-R
GENETICA Y EPIGENETICA DE TRASTORNOS PSIQUIATRICOS: TRASTORN...
218K€
Cerrado
Información proyecto MiND
Duración del proyecto: 48 meses
Fecha Inicio: 2014-12-19
Fecha Fin: 2018-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are frequent, chronic and highly heritable neurodevelopmental disorders. Despite their societal importance, progress in understanding disease biology has been slow and no curative treatment options are available.
The pan-European training network MiND aims to educate a new generation of researchers in the field of neurodevelopmental disorders, through innovation-oriented research combined with highly interdisciplinary and intersectoral international training.
Research and training in MiND span state-of-the-art topics in the fields of ADHD, ASD and their yet un-investigated overlap. We combine advanced (epi-)genetics approaches with bioinformatics and develop novel cell and animal models of increasing complexity to understand pathomechanisms. Integrated with research in large human DNA-neuroimaging-cognition data sets, we push forward the understanding of the biology leading from gene to cognition and disease. Our mechanistic work is embedded in a framework exploring alternative disease definitions for ADHD and ASD across the lifespan and working towards improved treatment: we use novel cognitive assessments, we probe the microbiome for dietary interventions reducing symptoms and evaluate mindfulness training as non-pharmacological treatment options, in addition to developing new compounds for pharmacological treatment optimization and individualization. The strategic collaboration of world-leading academic groups, research-intensive commercial enterprises and patient organisations will deliver 15 young, scientifically excellent researchers which are optimally prepared for private sector and academic careers.
MiND can be expected to impact patients and society by improving our understanding of disease biology, by developing novel diagnostic and treatment strategies, and by raising awareness for the necessity of research of neurodevelopmental disorders from childhood to adulthood.